264 related articles for article (PubMed ID: 10775585)
1. The carboxyl terminus of v-Abl protein can augment SH2 domain function.
Warren D; Heilpern AJ; Berg K; Rosenberg N
J Virol; 2000 May; 74(10):4495-504. PubMed ID: 10775585
[TBL] [Abstract][Full Text] [Related]
2. Disruption of the Shc/Grb2 complex during abelson virus transformation affects proliferation, but not apoptosis.
Baughn LB; Rosenberg N
J Virol; 2005 Feb; 79(4):2325-34. PubMed ID: 15681433
[TBL] [Abstract][Full Text] [Related]
3. The extreme carboxyl terminus of v-Abl is required for lymphoid cell transformation by Abelson virus.
Warren D; Griffin DS; Mainville C; Rosenberg N
J Virol; 2003 Apr; 77(8):4617-25. PubMed ID: 12663768
[TBL] [Abstract][Full Text] [Related]
4. Temperature-sensitive transformation by an Abelson virus mutant encoding an altered SH2 domain.
Mainville CA; Parmar K; Unnikrishnan I; Gong L; Raffel GD; Rosenberg N
J Virol; 2001 Feb; 75(4):1816-23. PubMed ID: 11160680
[TBL] [Abstract][Full Text] [Related]
5. Ras complements the carboxyl terminus of v-Abl protein in lymphoid transformation.
Parmar K; Rosenberg N
J Virol; 1996 Feb; 70(2):1009-15. PubMed ID: 8551558
[TBL] [Abstract][Full Text] [Related]
6. In vivo association of v-Abl with Shc mediated by a non-phosphotyrosine-dependent SH2 interaction.
Raffel GD; Parmar K; Rosenberg N
J Biol Chem; 1996 Mar; 271(9):4640-5. PubMed ID: 8617726
[TBL] [Abstract][Full Text] [Related]
7. Absence of p53 complements defects in Abelson murine leukemia virus signaling.
Unnikrishnan I; Rosenberg N
J Virol; 2003 Jun; 77(11):6208-15. PubMed ID: 12743277
[TBL] [Abstract][Full Text] [Related]
8. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides.
van der Geer P; Wiley S; Lai VK; Olivier JP; Gish GD; Stephens R; Kaplan D; Shoelson S; Pawson T
Curr Biol; 1995 Apr; 5(4):404-12. PubMed ID: 7542991
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine phosphorylation of Grb2 by Bcr/Abl and epidermal growth factor receptor: a novel regulatory mechanism for tyrosine kinase signaling.
Li S; Couvillon AD; Brasher BB; Van Etten RA
EMBO J; 2001 Dec; 20(23):6793-804. PubMed ID: 11726515
[TBL] [Abstract][Full Text] [Related]
10. Purification and molecular cloning of SH2- and SH3-containing inositol polyphosphate-5-phosphatase, which is involved in the signaling pathway of granulocyte-macrophage colony-stimulating factor, erythropoietin, and Bcr-Abl.
Odai H; Sasaki K; Iwamatsu A; Nakamoto T; Ueno H; Yamagata T; Mitani K; Yazaki Y; Hirai H
Blood; 1997 Apr; 89(8):2745-56. PubMed ID: 9108392
[TBL] [Abstract][Full Text] [Related]
11. Active Akt and functional p53 modulate apoptosis in Abelson virus-transformed pre-B cells.
Gong L; Unnikrishnan I; Raghavan A; Parmar K; Rosenberg N
J Virol; 2004 Feb; 78(4):1636-44. PubMed ID: 14747529
[TBL] [Abstract][Full Text] [Related]
12. SH2-containing inositol 5'-phosphatase inhibits transformation of Abelson murine leukemia virus.
Fessler SP; Rosenberg N; Baughn LB
J Virol; 2011 Sep; 85(17):9239-42. PubMed ID: 21697469
[TBL] [Abstract][Full Text] [Related]
13. Abl interactor 1 binds to sos and inhibits epidermal growth factor- and v-Abl-induced activation of extracellular signal-regulated kinases.
Fan PD; Goff SP
Mol Cell Biol; 2000 Oct; 20(20):7591-601. PubMed ID: 11003655
[TBL] [Abstract][Full Text] [Related]
14. The src homology 2 and phosphotyrosine binding domains of the ShcC adaptor protein function as inhibitors of mitogenic signaling by the epidermal growth factor receptor.
O'Bryan JP; Lambert QT; Der CJ
J Biol Chem; 1998 Aug; 273(32):20431-7. PubMed ID: 9685397
[TBL] [Abstract][Full Text] [Related]
15. Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathway.
Tauchi T; Boswell HS; Leibowitz D; Broxmeyer HE
J Exp Med; 1994 Jan; 179(1):167-75. PubMed ID: 7505797
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a novel member of the DOK family that binds and modulates Abl signaling.
Cong F; Yuan B; Goff SP
Mol Cell Biol; 1999 Dec; 19(12):8314-25. PubMed ID: 10567556
[TBL] [Abstract][Full Text] [Related]
17. Abl-interactor-1, a novel SH3 protein binding to the carboxy-terminal portion of the Abl protein, suppresses v-abl transforming activity.
Shi Y; Alin K; Goff SP
Genes Dev; 1995 Nov; 9(21):2583-97. PubMed ID: 7590237
[TBL] [Abstract][Full Text] [Related]
18. Shc phosphotyrosine-binding domain dominantly interacts with epidermal growth factor receptors and mediates Ras activation in intact cells.
Sakaguchi K; Okabayashi Y; Kido Y; Kimura S; Matsumura Y; Inushima K; Kasuga M
Mol Endocrinol; 1998 Apr; 12(4):536-43. PubMed ID: 9544989
[TBL] [Abstract][Full Text] [Related]
19. The tetramerization domain-independent Ras activation by BCR-ABL oncoprotein in hematopoietic cells.
Tauchi T; Okabe S; Miyazawa K; Ohyashiki K
Int J Oncol; 1998 Jun; 12(6):1269-76. PubMed ID: 9592185
[TBL] [Abstract][Full Text] [Related]
20. Gads is a novel SH2 and SH3 domain-containing adaptor protein that binds to tyrosine-phosphorylated Shc.
Liu SK; McGlade CJ
Oncogene; 1998 Dec; 17(24):3073-82. PubMed ID: 9872323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]